This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 1998;279:1153.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Moderate, daily doses of vitamin E sharply reduced the risk of prostate cancer in male smokers and also lowered their chances of dying from the disease, according to the latest results from a large prevention trial conducted by the National Cancer Institute (NCI) and the National Public Health Institute of Finland (J Natl Cancer Inst. 1998;90:440-446).

In the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study), 29133 Finnish male smokers 50-69 years of age were randomly assigned to receive a 50-mg daily dose of vitamin E (as -tocopherol), a 20-mg daily dose of beta carotene, both supplements, or a placebo. The latest analysis of the study's findings found that the men who received the daily dose of 50 mg of vitamin E—about 3 times the recommended daily allowance—for 5 to 8 years (and a median of 6.1 years) had one third fewer prostate cancer diagnoses and . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?